CWA
HUMA icon

Clarus Wealth Advisors’s Humacyte HUMA Stock Holding History

Clarus Wealth Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3K Hold
39,971
– – 0.01% 86
2026
Q1 		$24.3K Hold
39,971
– – 0.01% 88
2025
Q4 		$44.4K Hold
39,971
– – 0.02% 86
2025
Q3 		$83.9K Hold
39,971
– – 0.04% 86
2025
Q2 		$103K Sell
39,971
-1,179
-3% -$2.27K 0.05% 87
2025
Q1 		$63K Buy
41,150
+87
+0.2% +$327 0.03% 87
2024
Q4 		$180K Buy
+41,063
New +$203K 0.09% 118

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Clarus Wealth Advisors's HUMA Position: Q2 2026 in Review

Clarus Wealth Advisors held its Humacyte (HUMA) position steady in Q2 2026 at 39,971 shares worth $29.3K. The position accounts for 0.01% of the portfolio, ranked #86.

Clarus Wealth Advisors first reported a position in HUMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $180K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Clarus Wealth Advisors held 39,971 shares of Humacyte worth $29.3K as of Q2 2026.
  • Clarus Wealth Advisors left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up 0.01% of Clarus Wealth Advisors's portfolio in Q2 2026, its #86 holding.
  • Clarus Wealth Advisors first reported a position in Humacyte in Q4 2024 and has held it in 7 quarters since.
  • Clarus Wealth Advisors's Humacyte position peaked at $180K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Clarus Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.